CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 43 enrolled
Drug / intervention
Cochlear Implant +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02203305
NCT02203305N/ACompleted
CompareCT.gov

Cochlear Implantation in Cases of Single-Sided Deafness

University of North Carolina, Chapel Hill·interventional·Posted Jul 29, 2014·Updated Jul 25, 2022

In Brief

A clinical study evaluating Cochlear Implant and Control Group for Unilateral Moderate to Profound Hearing Loss and 2 related conditions. Completed, enrolled 43 participants across 1 site.

Detailed Summary

The primary goal of this project is to determine whether subjects with Single-Sided Deafness (SSD) experience an improvement in speech perception, localization, and quality of life with a cochlear implant as compared to an unaided listening condition.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUnilateral Moderate to Profound Hearing Loss, Asymmetric Hearing Loss, Single-Sided Deafness (SSD)
CountriesUnited States
CollaboratorsMed-El Corporation

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJul 29, 2014
Enrollment StartOct 1, 2014
Primary CompletionSep 16, 2021
TodayJul 2, 2026
Enrollment to primary: 7.0 yearsPosted 11.9 years ago

Interventions

Cochlear Implantdevice

cochlear implantation used a treatment for single-sided deafness and/or asymmetric hearing loss

Control Groupother

Subjects in the control group will have had listening experience with a bone-conduction device, which is an approved treatment for SSD.